Anxiety

Articles and therapies for treating anxiety, a space where you can find clear, up-to-date information on understanding this condition and the different ways of addressing it. In addition to traditional psychological treatments, innovative options are emerging—such as ketamine therapy—and new lines of research are studying the role of psilocybin, MDMA, and 5-MeO-DMT in cases that do not respond to traditional methods.

This content allows you to discover how each approach can help reduce internal tension, improve stress response, and provide tools to better manage episodes of anxiety. In specialised centres, treatments are always applied with strict clinical criteria and professional support to ensure a safe process tailored to each individual.

Marta Martín Islas

Ketamine for anxiety: a simple guide to new findings

Anxiety disorders are increasingly prevalent and often respond poorly to standard treatments such as SSRIs or benzodiazepines. Growing evidence suggests ketamine-assisted psychotherapy may offer rapid relief, particularly in treatment-resistant anxiety. By modulating glutamate via NMDA and AMPA receptors, ketamine enhances neuroplasticity and may reduce pathological worry within hours or days. Clinical trials show benefits in social and generalized anxiety, and real-world studies report sustained symptom reduction and decreased suicidal ideation. When combined with psychotherapy and integration, ketamine may help consolidate meaningful and lasting change.

...
Marta Martín Islas

Microdosing psychedelics: potential benefits and current evidence

Microdosing psychedelics involves taking sub-perceptual doses of substances such as psilocybin or LSD with the aim of improving mood, cognition and emotional wellbeing. This article reviews current scientific evidence on microdosing, including proposed neurobiological mechanisms, potential benefits for depression and anxiety, cognitive and motivational effects, safety considerations and the role of placebo. While observational studies suggest possible benefits, controlled trials show mixed results, highlighting important limitations and the need for further rigorous research before clear clinical recommendations can be made.

...

The information on this website is intended for healthcare professionals authorized to prescribe or dispense medications who practice their profession in Spain. Therefore, specialized training is required to interpret it correctly. The mentioned product may have a different authorized data sheet in other countries. By clicking the “Accept” button, you confirm that you are a healthcare professional authorized to prescribe or dispense medications and that you wish to access the information on this website in that capacity.